SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-22-061867
Filing Date
2022-03-02
Accepted
2022-03-01 20:51:21
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 d147359df3.htm F-3 537344
2 EX-1.2 d147359dex12.htm EX-1.2 239387
3 EX-4.2 d147359dex42.htm EX-4.2 275226
4 EX-4.3 d147359dex43.htm EX-4.3 308414
5 EX-5.1 d147359dex51.htm EX-5.1 53167
6 EX-5.2 d147359dex52.htm EX-5.2 15766
7 EX-23.1 d147359dex231.htm EX-23.1 1648
8 EX-FILING FEES d147359dexfilingfees.htm EX-FILING FEES 53770
9 GRAPHIC g147359dsp108.jpg GRAPHIC 2006
10 GRAPHIC g147359dsp117.jpg GRAPHIC 4967
11 GRAPHIC g147359dsp118.jpg GRAPHIC 2919
12 GRAPHIC g147359g04a47.jpg GRAPHIC 41731
  Complete submission text file 0001193125-22-061867.txt   1553836
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-263198 | Film No.: 22700878
SIC: 2834 Pharmaceutical Preparations